TRIPS-PLUS扩张下药品强制许可制度研究国际法学专业论文.docxVIP

1 1 Abstract Drug accessibility is a key factor to solve the public health problems, drug compulsory license system is one of the countries access to basic health drugs tool, while TRIPS-PLUS clause contains dominated by developed countries the bilateral or multilateral free trade agreement, the investment protection agreement will be affected during drug compulsory license system implementation. Public health and drug accessibility issues, is a world attention and constantly improve the degree of concern for public health issues. Current situation of China, good use of compulsory license system, is the key to solve the problem of public health, in line with international legal standards and domestic law case, an important tool can the compulsory license system can be used as a public health problem and the right balance of pharmaceutical patent protection conflict. This paper mainly studies the provisions on drug compulsory license system under the framework of WTO;The effects of drug compulsory license provisions related to public health in TRIPS-PLUS terms; TRIPS-PLUS standard to influence in some countries; and our country should influence how to control the TRIPS-PLUS clause on the drug compulsory license system. Key Words：Pharmaceutical compulsory license；US FTAS；TRIPS-PLUS 1 1 HYPERLINK \l _bookmark0 引 言 1 HYPERLINK \l _bookmark1 一、绪论 3 HYPERLINK \l _bookmark2 （一）论文研究的内容和方法 3 HYPERLINK \l _bookmark3 （二）国内和国外研究现状 3 HYPERLINK \l _bookmark4 （三）论文研究的目的和意义 6 HYPERLINK \l _bookmark5 二、WTO 框架下药品强制许可制度的规定 8 HYPERLINK \l _bookmark6 （一）强制许可制度的定义和分类 8 HYPERLINK \l _bookmark7 （二）药品强制许可制度的确立过程 11 HYPERLINK \l _bookmark8 （三）《多哈宣言》后药品强制许可制度的发展现状 14 HYPERLINK \l _bookmark9 三、与公共健康相关的 TRIPS-PLUS 条款中影响药品强制许可的规定 19 HYPERLINK \l _bookmark10 （一）TRIPS-PLUS 标准产生的重要原因 19 HYPERLINK \l _bookmark11 （二）TRIPS-PLUS 标准中与药品强制许可制度相关规定 22 HYPERLINK \l _bookmark12 四、美式 FTAS 中 TRIPS-PLUS 标准对一些国家的影响 29 HYPERLINK \l _bookmark13 （一）美国-澳大利亚 FTA 29 HYPERLINK \l _bookmark